Spatial and temporal regulation of coronary vessel formation by calcineurin-NFAT signaling.

Full Abstract

Formation of the coronary vasculature requires reciprocal signaling between endothelial, epicardially derived smooth muscle and underlying myocardial cells. Our studies show that calcineurin-NFAT signaling functions in endothelial cells within specific time windows to regulate coronary vessel development. Mouse embryos exposed to cyclosporin A (CsA), which inhibits calcineurin phosphatase activity, failed to develop normal coronary vasculature. To determine the cellular site at which calcineurin functions for coronary angiogenesis, we deleted calcineurin in endothelial, epicardial and myocardial cells. Disruption of calcineurin-NFAT signaling in endothelial cells resulted in the failure of coronary angiogenesis, recapitulating the coronary phenotype observed in CsA-treated embryos. By contrast, deletion of calcineurin in either epicardial or myocardial cells had no effect on coronary vasculature during early embryogenesis. To define the temporal requirement for NFAT signaling, we treated developing embryos with CsA at overlapping windows from E9.5 to E12.5 and examined coronary development at E12.5. These experiments demonstrated that calcineurin-NFAT signaling functions between E10.5 and E11.5 to regulate coronary angiogenesis. Consistent with these in vivo observations, endothelial cells exposed to CsA within specific time windows in tissue culture were unable to form tubular structures and their cellular responses to VEGF-A were blunted. Thus, our studies demonstrate specific temporal and spatial requirements of NFAT signaling for coronary vessel angiogenesis. These requirements are distinct from the roles of NFAT signaling in the angiogenesis of peripheral somatic vessels, providing an example of the environmental influence of different vascular beds on the in vivo endothelial responses to angiogenic stimuli.

Author information

Author/s: Zeini, Miriam (M); Hang, Calvin T (CT); Lehrer-Graiwer, Joshua (J); Dao, Tiffany (T); Zhou, Bin (B); Chang, Ching-Pin (CP);

Affiliation: Division of Cardiovascular Medicine, Department of Medicine, Stanford University, Stanford, CA 94305, USA.

Grants: 5T32 CA09302 (Agency:NCI NIH HHS) ; HL078881 (Agency:NHLBI NIH HHS) ; HL085345 (Agency:NHLBI NIH HHS) ; T32 HL007708 (Agency:NHLBI NIH HHS)

Journal and publication information

Publication Type: In Vitro; Journal Article; Research Support, N.I.H., Extramural; Research Support, Non-U.S. Gov't

Journal: Development (Cambridge, England) (Development), published in England. (Language: eng)

Reference: 2009-Oct; vol 136 (issue 19) : pp 3335-45

Dates: Created 2009/09/08; Completed 2009/10/14;

PMID: 19710169, status: MEDLINE (last retrieved date: 10/14/2009)

Sourced from the National Library of Medicine. Abstract text and other information may be subject to copyright.

External Links for this article
(including full text providers, if available):

Click Electronic Full-text Provider Links to see options for finding the electronic full text links to this article. Note there may be a subscription or fee required for access to the full text. See our FAQ for information on finding FREE full text articles.

This article may also be located in paper journal collections available in many libraries. Use the Journal and Publication Information above to find the full article.